LA Fox, LM Buckloh, SD Smith, T Wysocki, N … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Eleven subjects from each group completed the trial (age 46.3 ± 3.2 months [means
± SE]). At baseline, there were no differences between groups in HbA 1c , MBG, age, sex, diabetes
duration, or parental QOL. Mean HbA 1c , MBG, and parental QOL were similar between ... Cited by 73 - Related articles - All 9 versions
LA DiMeglio, TM Pottorff, SR Boyd, L France, N … - The Journal of pediatrics, 2004 - Elsevier Thirty-seven patients completed 6 months of therapy. There was a significant decrease in HbA1c
during the study period for both groups (from 8.9% ± 0.6% to 8.6% ± 0.6% at 3- and 6-month
visits). At 3 months, children using pumps had a significantly lower HbA1c than the ... Cited by 99 - Related articles - All 13 versions
DM Wilson, BA Buckingham, EL … - Diabetes …, 2005 - care.diabetesjournals.org.p. … RESULTS—The 19 subjects' ages ranged from 1.7 to 6.1 (mean 3.6) years, duration of diabetes
ranged from 0.6 to 2.6 (mean 1.4) years, and baseline HbA 1c ranged from 6.7 to 9.6% (mean
7.9%). Seven subjects were male. Nine subjects were randomized to start CSII and 10 to ... Cited by 109 - Related articles - All 7 versions
- ►input.me.uk [PDF] N Weintrob, H Benzaquen, A Galatzer, S Shalitin, L … - Pediatrics, 2003 - Am Acad Pediatrics Results. The changes in HbA 1c and fructoseamine values were similar in the 2 arms over
time. At the end of the study, mean HbA 1c level measured 8.05 ± 0.78%. There were no differences
between the treatment modes in frequency of symptomatic hypoglycemic or ... Cited by 135 - Related articles - BL Direct - All 7 versions
SM Willi, J Planton, L Egede, S Schwarz - The Journal of pediatrics, 2003 - Elsevier Before pump initiation, HbA 1C was relatively stable, but it fell to 7.7±0.2% (P<.001) within 3
months of CSII and remained decreased (7.9±0.1%) at 12 months (P<.01). In contrast, weight
standard deviation score increased before CSII (from 0.50±0.13 to 0.60±0.13, P<.05), but ... Cited by 77 - Related articles - All 5 versions
SA Weinzimer, JAH Ahern, EA Doyle, MR Vincent, J … - Pediatrics, 2004 - Am Acad Pediatrics Objective. Use of continuous subcutaneous insulin infusion (CSII) has increased dramatically
in recent years, and pump therapy has been shown to be a safe and effective alternative to multiple
daily injections in adults and older pediatric patients with type 1 diabetes. Its use in very ... Cited by 96 - Related articles - BL Direct - All 5 versions
SK McMahon, FL Airey, DA Marangou, KJ … - Diabetic …, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 64 - Related articles - BL Direct - All 5 versions
JE Mack-Fogg, CC Orlowski, N Jospe - Pediatric diabetes, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 35 - Related articles - All 3 versions
R Nimri, N Weintrob, H Benzaquen, R Ofan, G Fayman, … - Pediatrics, 2006 - Am Acad Pediatrics METHODS. The files of 279 patients who had type 1 diabetes and switched from multiple daily
injections to continuous subcutaneous insulin infusion between 1998 and 2003 were reviewed
for glycemic control, body mass index standard deviation score, and adverse events. ... Cited by 39 - Related articles - BL Direct - All 4 versions
